Form D · Biotechnology

MOAT BIOTECHNOLOGY Corp

Oklahoma City, OK · CIK 0001944095

Offering snapshot reported Oct 20, 2025 · SEC filing

Reported sold
$26.4K
Offering amount: $15.6M
Investors reported
1
Form D · investor count
Minimum accepted
$26.4K
Reported outside-investor minimum
First sale
Oct 3, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 20, 2025Initial$26,400No comparison1SEC filing
Feb 9, 2023Initial$101,640No comparison2SEC filing
Oct 11, 2022Amendment$1,500,000$500,000vs Sep 21, 20222SEC filing
Sep 21, 2022Initial$1,000,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$800K (estimated)
Form D file number
021-561383
The Corporation has retained a finder who may receive finders' fees. The maximum expected finders' fee is $800,000.

Source: Form D, filed Oct 20, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard A. Alvarez Executive
Tetherex Pharmaceuticals Corporation Promoter
Todd Foley Director
Phillip Jones Director
Philip A. Jones Director
Michael Moradi Araghi Director
Scott A. Rollins Director, Executive, Promoter
Russell P. Rother Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5501 White Fences Road
Oklahoma City, OK, 73131